The analysis evaluated visual acuity outcomes in CLN3 patients treated with Batten-1 (miglustat, n=11), versus untreated patients (n=22), using real-world data collected from natural history studies, ...

Beijing will conduct physical fitness tests on about 52,000 elementary and middle school students in the city from October 15 to November 8, and visual acuity will be counted as a "score" that will be ...

The Diabetic Retinopathy Clinical Research Network (DRCR.net) conducted a comparative effectiveness trial evaluating the prevalence of persistent diabetic macular edema (DME) and its effect on visual ...

Susvimo was nonferior to intravitreal ranibizumab based on the change from baseline in distance best corrected visual acuity score. The Food and Drug Administration (FDA) has approved Susvimo ® ...

Aflibercept, bevacizumab, and ranibizumab all improve vision in eyes with center-involved diabetic macular edema, according to a randomized clinical trial. The relative effect of the three drugs ...